Advertisement

Topics

Latest "Mini CarmGlobal Market Status Trend Report 20132023 Countries" News Stories

11:36 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Mini CarmGlobal Market Status Trend Report 20132023 Countries" found in our extensive news archives from over 250 global news sources.

More Information about Mini CarmGlobal Market Status Trend Report 20132023 Countries on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Mini CarmGlobal Market Status Trend Report 20132023 Countries for you to read. Along with our medical data and news we also list Mini CarmGlobal Market Status Trend Report 20132023 Countries Clinical Trials, which are updated daily. BioPortfolio also has a large database of Mini CarmGlobal Market Status Trend Report 20132023 Countries Companies for you to search.

Showing "Mini CarmGlobal Market Status Trend Report 20132023 Countries" News Articles 1–25 of 33,000+

Monday 18th March 2019

What’s New in Healthcare? | Infiniti Research Identifies Top Trends and Key Events That Would Redefine the Future of Healthcare

A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on healthcare industry analysis 2019. This article identifies the top healthcare industry trends and also provides insights into some key events that would revolutionize the future of


HAEMATO AG: Preliminary Results 2018

DGAP-News: HAEMATO AG / Key word(s): Preliminary Results 18.03.2019 / 15:14 The issuer is solely responsible for the content of this announcement. Corporate News of HAEMATO AG: HAEMATO AG was able to achieve an EBITDA of EUR 10.0m for the fiscal year 2018 according to preliminary IFRS financial statements. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved consolidated sales of EUR 27...

R&D Market Pulse: DOD and Car Companies Shift Funds for R&D

NewsR&D Index member Toyota announced last week that it is increasing its planned U.S. investments by about a third ($4 billion) to $13 billion through 2021.


Attica Bank (TATT) - Balance sheet repair nears completion

Edison Investment Research - Financials - Attica Bank: Through the Artemis and Metexelixis securitisations, Attica’s exposure to impaired loans has reduced significantly and now compares favourably with the larger Greek banks. Management forecasts common equity Tier 1 to increase from 12.2% to 13.2% at year end, representing significant headroom over regulatory requirements. Management will ...

The Health Plan of West Virginia, Inc. Engages Kentmere Healthcare Consulting Corporation for Outpatient Laboratory Benefit Management

The Health Plan of West Virginia, Inc., has brought in Kentmere Healthcare Consulting Corporation of Wilmington, Del. to increase quality and services of outpatient laboratory testing for physicians and members while decreasing the cost of testing. The Health Plan serves approximately 183,000 members, primarily in West Virginia and Ohio. This press release ...

Diagnostics Data Analytics Company Diaceutics to List on London Stock Exchange

Company seeking £53M IPO on London Stock Exchange junior market, AIM (Alternative Investment Market) Diaceutics expects the addressable market for its specific services to grow to US$2.5BN by 2023 Diaceutics plc, a revenue-generating and profitable diagnostics data analytics and implementation services company which ...

Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial

Aerpio Pharmaceuticals acknowledged the failure of its lead pipeline candidate in a Phase IIb trial in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR), triggering a selloff by investors that sent the company’s shares plunging by more than 70% in early market trading. AKB-9778 failed the Phase IIb TIME-2b trial (NCT03197870) by missing its […] The post Aerpio ...

miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer

New Highly-Sensitive Detection Technology using miRNA and snoRNA Expression Signatures Unveiled at EAU 2019 Proprietary, non-invasive liquid biopsy urine test definitively detects, accurately scores and continuously monitors prostate and bladder cancers miR Scienti

Zahlen von Wolftank, neue Marinomed-Preisschritte (gabb Neue Aktien)

Die im direct market plus der Wiener Börse gelistete Wolftank-Adisa hat Zahlen präsentiert. Die Gesellschaft konnte im Geschäftsjahr 2018 einen vorläufigen Konzern-Umsatz von 41,855 Mio. Euro, ein ...

P&G Sets New Goal to Deliver 25 Billion Liters of Clean Drinking Water to Families in Need Worldwide

After achieving its 2020 goal of delivering 15 billion liters one year early, the Company increases its target to 25 billion liters of clean water by 2025 This World Water Day, Procter & Gamble (P&G) is celebrating the achievement of its 2020 goal of delivering 15 billion liters of clean drinking water through its non-profit Children’s Safe D...

First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of FARXIGA in Type 2 Diabetes

FARXIGA reduced major adverse cardiovascular events by 16% in patients who had a prior heart attack FARXIGA reduced hospitalization for heart failure regardless of ejection fraction status Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that FARXIGA (dapagliflozin) reduced the relative ri...

Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space

A recent study in Frontiers in Bioengineering and Biotechnology showed uBiome and its executives as top inventors in the microbiome industry. SAN FRANCISCO (PRWEB) March 18, 2019 uBiome, the leader in microbial genomics, has the largest patent portfolio in the microbiome industry and the third highest quality portfolio following Seres Health and Nestle, as published in Frontiers in Bioengineering...

LivaNova Announces Trui Hebbelinck as Chief Human Resources Officer

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Trui Hebbelinck has been appointed Chief Human Resources Officer for the Company. Hebbelinck will lead global human resources, serve on the Executive Leadership Team and report to Chief Executive Officer Damien McDonald. “Trui brings incredible expertise to ...

Change Healthcare Releases the 9th Annual Industry Pulse Survey

U.S. healthcare leaders share insights on trends and issues facing payers, providers, and the businesses that serve the market. Top findings: Significant forces are causing payers and providers to rethink business models; a greater focus on social determinants of health; continued challenges with risk sharing Today Change Healthcare and the

Shield Compliance Launches Shield Data Hub to Streamline Cannabis Banking Compliance and Risk Management

New executive leadership and funding will enable company to expand operations to all 33 states with legalized cannabis. Shield Compliance (https://www.shieldbanking.com/), the industry’s only purpose-built AML/BSA compliance management and payment integrator system for banking legal marijuana-related businesses (MRBs), today announced the availabilit...

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering (the “Registered Direct Offering”) of 3,636,364 shares of...

3M Announces New Business Segments and Leadership Appointments

New Structure Increases Customer Focus, Agility and Productivity 3M today announced the realignment of the company from five to four business segments. The new alignment will enable the company to better serve global customers and markets. “We are continuing to advance 3M into the future, and today’s actions will strengthen our ability to ...

Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

- License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration. - OliX to receive an upfront payment of 2 million euro, and eligible to receive milestones, plus royalty for the development and commercialization in

Puma Biotechnology’s Licensing Partner Specialised Therapeutics Asia Receives Regulatory Approval to Commercialize NERLYNX® (neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

Neratinib becomes the first anti-HER2 treatment to be approved in Australia, as extended adjuvant therapy for early stage HER2-positive breast cancer following adjuvant trastuzumab-based therapy. Treatment with neratinib in the approved indication resulted in a 34% reduction in the risk of invasive disease recurrence or death ...

Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view

Hardman & Co Research 18-March-2019 / 11:30 GMT/BST Hardman & Co Research: Take an objective view AGY is a long-established specialist in the prevention, diagnosis and treatment of allergies. The Pollinex Quattro (PQ) platform, an ultra-short-course subcutaneous allergy immunotherapy (AIT), continues to gain market share despite its availability in the EU on a 'named-patient' basis o...

Neural Analytics, Inc. Announces the First Site Initiation and First Subject Enrollment into the CODEX Study, Utilizing Autonomous Robotic Transcranial Doppler Technology

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announces today the first site initiation and first subjects enrolled into the CODEX Study, a prospective, single arm multi-center safety and technical feasibility study utilizing an investigational iteration of the Lucid Roboti...

Hilton Brands to Recycle 1 Million Bars of Soap by Global Handwashing Day

Partnering with Clean the World, Hilton’s participating brands will recycle soap and donate to communities in need around the world Hilton’s (NYSE: HLT) Hilton Garden Inn, Hampton by Hilton and All Suites brands are launching the Clean the World Challenge in partnership with Clean

State Highlights: Advocates Push For Better Health Care Access For Transgender Patients In Md., Va.; Oregon Houses Nearly 400 Foster Children In Institutional Settings

Media outlets report on news from Maryland, Virginia, Oregon, Connecticut, Colorado, Texas, Ohio, Pennsylvania, Louisiana, Georgia, Florida, Massachusetts, Minnesota and Missouri.

Washing Soda Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Washing Soda report provides an independent information about the Washing Soda industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The report woul...

CSPC Pharmaceutical Announces 2018 Annual Results

Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks